EGRX

Eagle Pharmaceuticals, Inc.

Delisted

EGRX was delisted on the 2nd of October, 2024.

65 hedge funds and large institutions have $31.9M invested in Eagle Pharmaceuticals, Inc. in 2024 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 28 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
-10
Holders Change %
-13.33%
% of All Funds
0.94%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
11
Reduced
28
Closed
21
Calls
$3.74M
Puts
$4K
Net Calls
+$3.73M
Net Calls Change
-$1.93M
Name Holding Trade Value Shares
Change
Shares
Change %
FCP
76
Fidelis Capital Partners
Florida
-$54.2K -12,762 Closed
Mackenzie Financial
77
Mackenzie Financial
Ontario, Canada
-$60.4K -10,786 Closed
SEI Investments
78
SEI Investments
Pennsylvania
-$56.4K -10,076 Closed
SOW
79
State of Wyoming
Wyoming
-$45.5K -8,118 Closed
RhumbLine Advisers
80
RhumbLine Advisers
Massachusetts
-$40.6K -7,246 Closed
Mirae Asset Global ETFs Holdings
81
Mirae Asset Global ETFs Holdings
Hong Kong
-$27.3K -4,881 Closed
JPMorgan Chase & Co
82
JPMorgan Chase & Co
New York
-$13K -2,317 Closed
Carson Wealth (CWM LLC)
83
Carson Wealth (CWM LLC)
Nebraska
-$9K -1,672 Closed
Macquarie Group
84
Macquarie Group
Australia
-$2.9K -518 Closed
Wells Fargo
85
Wells Fargo
California
-$1.97K -351 Closed
New York State Common Retirement Fund
86
New York State Common Retirement Fund
New York
-$1K -90 Closed